| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |